The ongoing 2022 multicountry outbreak of monkeypox is the largest in history to occur
outside of Africa. Monkeypox is an emerging zoonotic disease that for decades has been …

Monkeypox is a zoonotic disease that was once endemic in west and central Africa caused
by monkeypox virus. However, cases recently have been confirmed in many nonendemic …

Background Cases of human monkeypox are rarely seen outside of west and central Africa.
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …

Background Human monkeypox (MPX) is a neglected zoonotic disease caused by the MPX
virus a double-stranded DNA virus which belongs to the Poxviridae family genus …

Data relevant to the use of tecovirimat, brincidofovir, cidofovir, trifluridine ophthalmic
solution, and vaccinia immune globulin intravenous were reviewed. Animal models, MCM …

ABSTRACT Introduction Tecovirimat (TPOXX®; ST-246) was approved for the treatment of
symptomatic smallpox by the USFDA in July of 2018 and has been stockpiled by the US …

The monkeypox disease is a zoonotic-infectious disease that transmits between animals
and humans. It is caused by a double-stranded DNA virus belonging to the Orthopoxvirus …

Abstract Infection caused by Monkeypox Virus (MPVX) has small rodents as its natural
reservoir and both monkeys and humans are occasional hosts. The causative agent is an …

Mpox virus is an emergent human pathogen. While it is less lethal than smallpox, it can still
cause significant morbidity and mortality. In this review, we explore 3 antiviral agents with …

Monkeypox (MPX) has recently made international headlines for the rapid and simultaneous
progression of the disease across the world. This review aims at summarizing the literature …